Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Friday, 17 February 2017

Nexstim Oyj (FI) - Publishing of Nexstim Plc 2016 Full Year Results

Nexstim Oyj    

Published: 08:00 CET 17-02-2017 /GlobeNewswire /Source: Nexstim Oyj / : NXTMH /ISIN: FI4000102678

Publishing of Nexstim Plc 2016 Full Year Results

Company announcement, Helsinki, 17 February 2017, at 9 am


Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, will announce its full year results for the year ended 31 December 2016 in the morning of Monday 28 February 2017.

A conference call for analysts, investors and media will take place at 16:00 Finnish time (EET) on Monday 28 February 2017, hosted by Martin Jamieson, Chairman of the Board and CEO, and Mikko Karvinen, CFO, who will present the financial and operational results followed by a Q&A session.

The dial-in numbers for the conference call are:

Finland: +358 (0) 800 914672

Sweden: +46 (0) 20 089 6388

UK: +44 (0) 20 3003 2666

US: + 1 866 966 5335

Standard International: +44 (0) 20 3003 2666


The call Password is Nexstim




Martin Jamieson, Chairman and CEO


Further information is available on the website www.nexstim.com or by contacting:


Nexstim                                                                +447715163942

Martin Jamieson, Chairman and CEO martin.jamieson@nexstim.com


UB Securities Oy (Certified Adviser)           +358 (0)9 2538 0246


Citigate Dewe Rogerson                        +44 (0)207 2821066

Katja Stout                                        katja.stout@citigatedr.co.uk


About Nexstim Plc

Nexstim is a medical technology company which has pioneered its technology in brain diagnostics with the Navigated Brain Stimulation (NBS) system as the first and only FDA-cleared and CE-marked navigated Transcranial Magnetic Stimulation (nTMS) system for pre-surgical mapping of the motor and speech cortices. Based on the same technology platform, the Company has developed a system called Navigated Brain Therapy (NBT®) which is CE-marked for chronic neuropathic pain, major depression and stroke therapy. Nexstim's shares are listed on Nasdaq First North Finland and Nasdaq First North Sweden. For more information please visit www.nexstim.com

Publishing of Nexstim Plc 2016 Full Year Results

This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of NASDAQ OMX Corporate Solutions clients. Source: Nexstim Oyj, Elimäenkatu 9 B, Helsinki FI 00510, Suomi
If you would like to unsubscribe and stop receiving these e-mails click here.